| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Bausch Health Companies Inc. last filed a Form 4 in June 2022, as 10% Owner at BLCO.
At the last filing, the largest reported position was 310,449,643 shares of BLCO. The BLCO filings lean toward selling, a net 39,550,357 shares.
Bausch Health Companies Inc. has 2 Form 4 filings on record from May 2022 to June 2022, all as 10% Owner at Bausch & Lomb (BLCO), 2022.
The 2 reported transactions were 2 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $674.5M.
The largest open-market sale was 35,000,000 shares of BLCO at an average $17.05 on May 10, 2022, about $596.9M. Twelve months later BLCO was up 5%.
Shares as reported in the last Form 4 for each company; the most recent is from June 2022. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.